Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    Migraine AND bms-927711
Show Display Options
Rank Status Study
1 Completed Dose Ranging Study of a Drug for the Treatment of Acute Migraine
Condition: Migraine - Acute
Interventions: Drug: Placebo matching BMS-927711;   Drug: BMS-927711;   Drug: Sumatriptan
2 Completed Study to Evaluate the PK of BMS-927711 in Patient With Migraine During Acute Migraine and Non-migraine Condition
Condition: Migraine
Intervention: Drug: BMS-927711 (CGRP Antagonist)

Indicates status has not been verified in more than two years